Efficacy of Pleurodesis and EGFR TKI in the Treatment of Lung Cancer-mediated Pleural Effusion with EGFR Mutation

被引：0
|
作者：
Li, Kunlin [1 ]
Zhao, Qian [1 ]
Zhang, Peng [2 ]
机构：
[1] Daping Hosp, Chongqing, Peoples R China
[2] Sichuan Int Studies Univ, Chongqing, Peoples R China
来源：
EUROPEAN RESPIRATORY JOURNAL | 2020年 / 56卷
关键词：
Quality of life; Lung cancer - management; Pleura;
D O I：
10.1183/13993003.congress-2020.1148
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
1148
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [1] Detection of EGFR mutation in the sample of pleural effusion is contributive as a determinant of EGFR-TKI-therapy for the patients with lung cancer
    Uchida, A.
    Shibayama, T.
    Takahashi, S.
    Hamada, N.
    Kawata, N.
    Tada, A.
    Soda, R.
    Takahashi, K.
    EJC SUPPLEMENTS, 2008, 6 (12): : 170 - 170
  • [2] Efficacy of EGFR-TKI for malignant pleural effusion in lung adenocarcinoma patients
    Chung, Chi-Li
    Lee, Kai-Ling
    Hsiao, Shih-Hsin
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [3] EGFR Mutation Status in Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Efficacy of EGFR Tyrosine Kinase Inhibitors
    Yang, Jiyoul
    Lee, Ok-Jun
    Son, Seung-Myoung
    Woo, Chang Gok
    Jeong, Yusook
    Yang, Yaewon
    Kwon, Jihyun
    Lee, Ki Hyeong
    Han, Hye Sook
    CANCER RESEARCH AND TREATMENT, 2018, 50 (03): : 908 - 916
  • [4] Efficacy of EGFR-TKI for Lung Adenosquamous Cell Carcinoma Harboring EGFR Mutation
    Liu, Y.
    Xia, X.
    Du, W.
    Zhang, Y.
    Xu, J.
    Gong, Y.
    Zhu, J.
    Ding, Z.
    Peng, F.
    Huang, M.
    Xu, Y.
    Wan, J.
    Ren, L.
    Lu, Y.
    Han, B.
    Wang, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2380 - S2380
  • [5] Efficacy of recombinant adenoviral human p53 gene in the treatment of lung cancer-mediated pleural effusion
    Li, Kun-Lin
    Kang, Jun
    Zhang, Peng
    Li, Li
    Wang, Yu-Bo
    Chen, Heng-Yi
    He, Yong
    ONCOLOGY LETTERS, 2015, 9 (05) : 2193 - 2198
  • [6] Frequency of EGFR mutations in lung adenocarcinoma with malignant pleural effusion: Implication of cancer biological behaviour regulated by EGFR mutation
    Zou, JianYong
    Bella, Amos Ela
    Chen, ZhenGuang
    Han, XiangQian
    Su, ChunHua
    Lei, YiYan
    Luo, HongHe
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2014, 42 (05) : 1110 - 1117
  • [7] TKI and Intrathoracic Perfusion in First-line Stage IV Lung Adenocarcinoma with EGFR Mutation and Malignant Pleural Effusion
    Huang, W.
    Li, P.
    Xu, H.
    Xu, K.
    Weng, J.
    Zhang, Y.
    Liu, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S630 - S631
  • [8] Significance of pleural effusion for EGFR mutation detection in non-small cell lung cancer
    Zhang Xiaozhu
    Zhao Yi
    Wang Miao
    Yap, Wee See
    Chang, Alex Y.
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S406 - S406
  • [9] The Impact of Sequence of Chemotherapy and EGFR-TKI Treatment on Different EGFR Mutation Lung Adenocarcinoma
    Chung, Fu-Tsai
    Ho, Ming-Yun
    Fang, Yueh-Fu
    Hshieh, Meng-Heng
    Wang, Tsai-Yu
    Kuo, Chih-Hsi
    Chen, Hao-Cheng
    Wang, Chun-Hwa
    Lin, Shu-Min
    Yu, Chih-Teng
    Lin, Horng-Chyuan
    Kuo, Han-Pin
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [10] RELEVANCE BETWEEN CEA LEVEL AND EGFR MUTATION, EFFICACY OF EGFR-TKI IN PATIENTS WITH LUNG ADENOCARCINOMA
    Zhang, Wei Y.
    Han, Hui B.
    Jin, Bo
    Shao, Hua M.
    Dong, Yu
    Huang, Mi A.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S891 - S891
12345